ConductScience.org, home

Paper39301658

Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).

Qu P and 10 others. Int J Mol Med, 2024. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). Papers, record 39301658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39301658

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).
PubMed
Journal
Int J Mol Med
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
2.51, provisional
iCite
Revised in PubMed
2024-09-22
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qu PPeng
2Li LLanfang
3Jin QQi
4Liu DDonghai
5Qiao YYuan
6Zhang YYijia
7Sun QQiuyue
8Ran SShuman
9Li ZZecheng
10Liu TTongtong
11Peng LLiang

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetic NephropathiesMajor topic
HistonesMajor topic
Epigenesis, GeneticMajor topic
Humans
Animals
Methylation
Protein Processing, Post-Translational
Histone Code

Source PubMed

Download CSV of topics

References161

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135918708Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation.J Biol Eng2022https://conductscience.org/library/papers/35918708PubMed
226534922The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes.J Am Soc Nephrol2016https://conductscience.org/library/papers/26534922PubMed
337166978Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression.J Clin Invest2023https://conductscience.org/library/papers/37166978PubMed
428450737Writing, erasing and reading histone lysine methylations.Exp Mol Med2017https://conductscience.org/library/papers/28450737PubMed
531367244A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep.Theranostics2019https://conductscience.org/library/papers/31367244PubMed
626444031Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.Kidney Int2016https://conductscience.org/library/papers/26444031PubMed
729361307Renal tubule injury: a driving force toward chronic kidney disease.Kidney Int2018https://conductscience.org/library/papers/29361307PubMed
831917689Regeneration after acute kidney injury requires PTIP-mediated epigenetic modifications.JCI Insight2020https://conductscience.org/library/papers/31917689PubMed
938897443The landscape of histone modification in organ fibrosis.Eur J Pharmacol2024https://conductscience.org/library/papers/38897443PubMed
1031866860Histone Methyltransferases as Therapeutic Targets for Kidney Diseases.Front Pharmacol2019https://conductscience.org/library/papers/31866860PubMed
1137105173Polycomb Ezh1 maintains murine muscle stem cell quiescence through non-canonical regulation of Notch signaling.Dev Cell2023https://conductscience.org/library/papers/37105173PubMed
1233639232Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.Pharmacol Res2021https://conductscience.org/library/papers/33639232PubMed
1322473383Histone methylation: a dynamic mark in health, disease and inheritance.Nat Rev Genet2012https://conductscience.org/library/papers/22473383PubMed
1439073023Galectin 3-binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor-β1 (TGF-β1) availability and inhibits hepatocarcinogenesis.Cancer Commun (Lond)2024https://conductscience.org/library/papers/39073023PubMed
1534508249The Mesangial cell - the glomerular stromal cell.Nat Rev Nephrol2021https://conductscience.org/library/papers/34508249PubMed
1618598942Menin critically links MLL proteins with LEDGF on cancer-associated target genes.Cancer Cell2008https://conductscience.org/library/papers/18598942PubMed
1733035459Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.Lancet Oncol2020https://conductscience.org/library/papers/33035459PubMed
1832162523Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.J Nat Prod2020https://conductscience.org/library/papers/32162523PubMed
1923200123Histone lysine methylation dynamics: establishment, regulation, and biological impact.Mol Cell2012https://conductscience.org/library/papers/23200123PubMed
2038298064Development of Complementary Photo-arginine/lysine to Promote Discovery of Arg/Lys hPTMs Interactomes.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38298064PubMed

See all 161 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42756949Epigenetic strategies for mitigating kidney fibrosis.PeerJ2026https://conductscience.org/library/papers/42756949PubMed
42554966Deubiquitinase USP7 stabilizes the histone demethylase KDM5B and promotes the progression of renal fibrosis through the TSC1/mTOR axis.Mol Biomed2026https://conductscience.org/library/papers/42554966PubMed
42416898Regulatory networks of post-translational modifications in diabetic kidney disease: from pathogenic mechanisms to therapeutic frontiers.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42416898PubMed
42318940Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review).Int J Mol Med2026https://conductscience.org/library/papers/42318940PubMed
41992968Glycolytic lactylation modulates cell death decisions in diabetic kidney disease: Metabolic‑epigenetic interplay between ferroptosis and autophagy in fibrotic remodeling (Review).Int J Mol Med2026https://conductscience.org/library/papers/41992968PubMed
41845912Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review.Ren Fail2026https://conductscience.org/library/papers/41845912PubMed
41782138The role of histone methylation in fibrosis and its therapeutic potential.J Transl Med2026https://conductscience.org/library/papers/41782138PubMed
41685570Post‑translational modifications in diabetic kidney disease (Review).Int J Mol Med2026https://conductscience.org/library/papers/41685570PubMed
41585789Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41585789PubMed
41540054Improving erectile function in diabetic male mice by rescuing depalmitoylated FBP1 to reduce cavernosal lactate.Nat Commun2026https://conductscience.org/library/papers/41540054PubMed
40828784Role of nuclear receptors, lipid metabolism, and mitochondrial function in the pathogenesis of diabetic kidney disease.Am J Physiol Renal Physiol2025https://conductscience.org/library/papers/40828784PubMed
40682843Protective effect of exercise on metabolic dysfunction‑associated fatty liver disease: Potential epigenetic mechanisms (Review).Int J Mol Med2025https://conductscience.org/library/papers/40682843PubMed
40564143Pathogenesis and Therapeutic Perspectives of Tubular Injury in Diabetic Kidney Disease: An Update.Biomedicines2025https://conductscience.org/library/papers/40564143PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39301658

GET https://conductscience.org/api/papers/v1/39301658/references?page=2